FDA.reportPublic FDA data

MOMETASONE FUROATE

Substance profile for UNII 04201GDN4R, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for MOMETASONE FUROATE
Structure render from PubChem CID 441336

Substance Identity#

UNII
04201GDN4R
Preferred term
MOMETASONE FUROATE
Registry number
83919-23-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C27H30Cl2O6
Chemical structure for MOMETASONE FUROATE
Structure render from PubChem CID 441336

Chemical And Database Identifiers#

InChIKey
WOFMFGQZHJDGCX-ZULDAHANSA-N
SMILES
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(OC(=O)C5=CC=CO5)C(=O)CCl
RxCUI
30145
PubChem
441336
NCIt
C29268
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound441336https://pubchem.ncbi.nlm.nih.gov/compound/441336
PubChem InChIKey SearchWOFMFGQZHJDGCX-ZULDAHANSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=WOFMFGQZHJDGCX-ZULDAHANSA-N
RxNorm30145https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=30145
NCI ThesaurusC29268https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29268
FDA Substance Registration System04201GDN4Rhttps://precision.fda.gov/uniisearch/srs/unii/04201GDN4R

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMometasone Furoate Ointment 0.1% For dermatologic use only- not for ophthalmic use1
Mometasone FuroateACTIVE MOIETY04201GDN4RMometasone Furoate Ointment 0.1% For dermatologic use only- not for ophthalmic use1
Mometasone FuroateACTIVE INGREDIENT04201GDN4Rdb303d11-eba4-49f7-bf9c-7d944ddb43e71
Mometasone FuroateACTIVE MOIETY04201GDN4Rdb303d11-eba4-49f7-bf9c-7d944ddb43e71
MOMETASONE FUROATEACTIVE MOIETY04201GDN4Rc337bce8-27e9-48fd-85fa-381d0242a36a1
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4Rc337bce8-27e9-48fd-85fa-381d0242a36a1
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RThese highlights do not include all the information needed to use NASONEX safely and effectively. See full prescribing information for NASONEX. NASONEX ® (mometasone furoate monohydrate) Nasal Spray 50 mcg † † calculated on the anhydrous basis Initial U.S. Approval: 19971
Mometasone FuroateACTIVE MOIETY04201GDN4RMometasone Furoate Cream 0.1% For Dermatologic Use Only Not for Ophthalmic Use1
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMometasone Furoate Cream 0.1% For Dermatologic Use Only Not for Ophthalmic Use1
MOMETASONE FUROATEACTIVE MOIETY04201GDN4R8c0c49c9-aa28-4587-869e-b403681525402
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4R8c0c49c9-aa28-4587-869e-b403681525402
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RThese highlights do not include all the information needed to use ASMANEX ® TWISTHALER ® safely and effectively. See full prescribing information for ASMANEX TWISTHALER. ASMANEX TWISTHALER 110 mcg, 220 mcg (mometasone furoate inhalation powder) Initial U.S. Approval: 19871
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4R0edf333a-776d-45b8-b567-acc863f8599b1
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMometasone Furoate Cream USP 0.1%1
MOMETASONE FUROATEACTIVE MOIETY04201GDN4RMOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%)2
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE LOTION (MOMETASONE FUROATE TOPICAL SOLUTION USP 0.1%)2
mometasone furoateACTIVE INGREDIENT04201GDN4RMometasone Furoate Lotion 0.1% (mometasone furoate topical solution USP)1
mometasone furoateACTIVE INGREDIENT04201GDN4RDULERA (MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE) AEROSOL [MERCK SHARP & DOHME CORP.]24
Mometasone FuroateACTIVE INGREDIENT04201GDN4RASMANEX (MOMETASONE FUROATE) INHALANT [MERCK SHARP & DOHME CORP.]13
Mometasone FuroateACTIVE INGREDIENT04201GDN4RELOCON (MOMETASONE FUROATE) LOTION [MERCK SHARP & DOHME CORP.]10
Mometasone FuroateACTIVE INGREDIENT04201GDN4RELOCON (MOMETASONE FUROATE) CREAM [MERCK SHARP & DOHME CORP.]9
mometasone furoateACTIVE INGREDIENT04201GDN4RELOCON (MOMETASONE FUROATE) OINTMENT [MERCK SHARP & DOHME CORP.]9
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [GLENMARK PHARMACEUTICALS INC., USA]5
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE OINTMENT [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]5
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RASMANEX HFA (MOMETASONE FUROATE) AEROSOL [MERCK SHARP & DOHME CORP.]4
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]4
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE LOTION [GLENMARK PHARMACEUTICALS INC., USA]4
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE SOLUTION [E. FOUGERA & CO. A DIVISION OF FOUGERA PHARMACEUTICALS INC.]4
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE SOLUTION [TARO PHARMACEUTICALS U.S.A., INC.]4
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE (MOMETASONE FUROATE) SOLUTION [G&W LABORATORIES, INC.]3
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE LOTION [GLOBAL PHARMACEUTIALS, DIVISION OF IMPAX LABORATORIES, INC.]3
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE OINTMENT [GLENMARK PHARMACEUTICALS INC., USA]3
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE OINTMENT [GLOBAL PHARMACEURICALS, DIVISION OF IMPAX LABORATORIES, INC.]3
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RPROPEL () KIT PROPEL MINI () KIT [INTERSECT ENT, INC.]3
MOMETASONE FUROATEACTIVE MOIETY04201GDN4RPROPEL () KIT PROPEL MINI () KIT [INTERSECT ENT, INC.]3
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE (MOMETASONE FUROATE) CREAM [G&W LABORATORIES, INC.]2
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE (MOMETASONE FUROATE) CREAM [HARRIS PHARMACEUTICAL, INC.]2
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE (MOMETASONE FUROATE) OINTMENT [G&W LABORATORIES, INC.]2
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE (MOMETASONE FUROATE) OINTMENT [HARRIS PHARMACEUTICAL, INC.]2
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE (MOMETASONE FUROATE) SOLUTION [HARRIS PHARMACEUTICAL, INC.]2
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [GLOBAL PHARMACEURICALS, DIVISION OF IMPAX LABORATORIES, INC.]2
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [PERRIGO NEW YORK INC.]2
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [TARO PHARMACEUTICALS U.S.A., INC.]2
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE OINTMENT [PERRIGO NEW YORK INC]2
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.]2
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE SOLUTION [PERRIGO NEW YORK INC]2
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RCLARO OTIC SOLUTION ((FLORFENICOL, TERBINAFINE, MOMETASONE FUROATE)) SOLUTION [BAYER HEALTHCARE, LLC ANIMAL HEALTH DIVISION]1
Mometasone FuroateACTIVE INGREDIENT04201GDN4RELOCON (MOMETASONE FUROATE) CREAM [A-S MEDICATION SOLUTIONS LLC]1
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [CLINICAL SOLUTIONS WHOLESALE]1
MOMETASONE FUROATEACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [PROFICIENT RX LP]1
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE CREAM [PROFICIENT RX LP]1
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE OINTMENT [REMEDYREPACK INC. ]1
Mometasone FuroateACTIVE INGREDIENT04201GDN4RMOMETASONE FUROATE OINTMENT [REMEDYREPACK INC. ]1
Mometasone FuroateACTIVE INGREDIENT04201GDN4RPOSATEX (ORBIFLOXACIN, MOMETASONE FUROATE, AND POSACONAZOLE) SUSPENSION [SCHERING CORPORATION]1